Related Experiment Videos
Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated
1Department of Cell and Molecular Biology, Institute of Cancer Research, London, UK.
Abstract:
The growth suppressive activity of the retinoblastoma tumour suppressor protein is controlled by cell cycle dependent phosphorylation. However, while many in vivo phosphorylation sites have been mapped, the identities of those residues whose phosphorylation is regulated remain elusive. We have mapped the epitopes of three independent monoclonal antibodies that recognise a distinction between differentially phosphorylated pRB sub-populations. All three antibodies recognise an identical epitope which encompasses an essential serine positioned within a consensus site for proline directed kinase phosphorylation. We provide evidence that this residue, serine 608 of pRB, is an authentic phosphorylation site that can be phosphorylated in vitro by cyclin A-CDK2 and cyclin D1-CDK4 kinases but not by cyclin E-CDK2 kinase or the mitogen activated kinase ERK2. Phosphorylation at this residue seems to be cell cycle regulated, occurring prior to entry into the S phase.
Insights
Researchers identified a key phosphorylation site on the retinoblastoma protein (pRB) that regulates its growth suppressive activity. This finding sheds light on cell cycle control and cancer development.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The retinoblastoma protein (pRB) is a crucial tumor suppressor.
- Its growth suppressive activity is regulated by cell cycle-dependent phosphorylation.
- Specific phosphorylation sites controlling pRB activity remain largely unidentified.
Purpose of the Study:
- To identify and characterize specific phosphorylation sites on pRB that are regulated during the cell cycle.
- To map antibody epitopes that distinguish between differentially phosphorylated pRB forms.
Main Methods:
- Epitope mapping of monoclonal antibodies recognizing distinct pRB phosphorylation states.
- In vitro kinase assays using purified kinases and pRB.
- Identification of specific serine residues as phosphorylation sites.
Main Results:
- Three monoclonal antibodies recognized an identical epitope on pRB.
- This epitope contains serine 608, a proline-directed kinase phosphorylation consensus site.
- Serine 608 is an authentic phosphorylation site, phosphorylated by cyclin A-CDK2 and cyclin D1-CDK4 in vitro.
- Phosphorylation at serine 608 appears to be cell cycle-regulated, preceding S phase entry.
Conclusions:
- Serine 608 is a key cell cycle-regulated phosphorylation site on the retinoblastoma protein (pRB).
- Identification of this site provides new insights into pRB regulation and its role in cell cycle control.
- This discovery has implications for understanding tumor suppression and developing cancer therapies.